Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma
Phase I/II Trial of Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma
Sponsor: Instituto do Cancer do Estado de São Paulo
Terminated
Burocracy and funding
Other terminated trials from Instituto do Cancer do Estado de São Paulo
- Adrenal Neoplasm · Phase NA · May 2023
- COVID · Phase PHASE2 · Jun 2022
- Gastrointestinal Hemorrhage · Phase NA · Aug 2020
- Rectal Cancer · Phase NA · Apr 2020
- Solid Tumor · Phase PHASE2 · Sep 2019
See all terminations from Instituto do Cancer do Estado de São Paulo
A PHASE2 clinical study on Plasmacytoma, this trial is terminated or withdrawn. The trial is conducted by Instituto do Cancer do Estado de São Paulo and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
May 2022 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Mar 2021 — May 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE2
▶ Show 3 earlier versions
-
Oct 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting · Phase: PHASE1_PHASE2 → PHASE2
-
Jun 2018 — Oct 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto do Cancer do Estado de São Paulo
For direct contact, visit the study record on ClinicalTrials.gov .